Havn Life Sciences Inc (HAVN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in thousands)
| 01-2023 | 10-2022 | 07-2022 | 04-2022 | 01-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | -23 | 46 | 165 | 132 |
| Accounts receivable | 220 | -250 | 55 | -201 | 257 |
| Other Working Capital | 813 | 179 | 133 | -205 | 33 |
| Other Operating Activity | -744 | -464 | -1,125 | -1,209 | -1,868 |
| Operating Cash Flow | $289 | $-558 | $-891 | $-1,450 | $-1,446 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | 28 | -17 |
| Investing Cash Flow | $0 | $0 | $0 | $28 | $-17 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -284 | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 33 | -33 | -33 | -33 |
| Common Stock Issued | N/A | N/A | N/A | 2,000 | N/A |
| Other Financing Activity | 0 | 422 | -20 | -334 | 0 |
| Financing Cash Flow | $-284 | $454 | $-53 | $1,633 | $-33 |
| Beginning Cash Position | 9 | 112 | 1,056 | 845 | 2,340 |
| End Cash Position | 14 | 9 | 112 | 1,056 | 845 |
| Net Cash Flow | $5 | $-104 | $-943 | $211 | $-1,495 |
| Free Cash Flow | |||||
| Operating Cash Flow | 289 | -558 | -891 | -1,450 | -1,446 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -17 |
| Free Cash Flow | 289 | -558 | -891 | -1,450 | -1,463 |